Another Pharmaceutical Firm Settles SEC Bribery Charges

Posted 3/8/16

Yet another global healthcare company has settled charges of bribing Chinese healthcare providers (HCPs) to increase sales. SciClone Pharmaceuticals agreed Feb. 4, 2016, to pay a total of $12.8 …

This item is available in full to subscribers.

Please log in to continue

Log in